These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32163308)

  • 1. Recent advances in potential targets for eosinophilic esophagitis treatments.
    Oliva S; Azouz NP; Stronati L; Rothenberg ME
    Expert Rev Clin Immunol; 2020 Apr; 16(4):421-428. PubMed ID: 32163308
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications.
    Ruffner MA; Kennedy K; Cianferoni A
    Expert Rev Clin Immunol; 2019 Jan; 15(1):83-95. PubMed ID: 30394139
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice.
    Arias Á; Lucendo AJ
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):99-117. PubMed ID: 30791784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging drugs for eosinophilic esophagitis.
    Pesek RD; Gupta SK
    Expert Opin Emerg Drugs; 2018 Jun; 23(2):173-183. PubMed ID: 29848130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic Esophagitis: the Potential Role of Biologics in its Treatment.
    Choudhury S; Baker S
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):150-159. PubMed ID: 31175521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic esophagitis in the era of biologics.
    Rossi CM; Santacroce G; Lenti MV; di Sabatino A
    Expert Rev Gastroenterol Hepatol; 2024 Jun; 18(6):271-281. PubMed ID: 38940016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies.
    Lucendo AJ
    Expert Rev Clin Immunol; 2020 Jan; 16(1):63-77. PubMed ID: 31842634
    [No Abstract]   [Full Text] [Related]  

  • 8. Medical and dietary management of eosinophilic esophagitis.
    Nhu QM; Aceves SS
    Ann Allergy Asthma Immunol; 2018 Aug; 121(2):156-161. PubMed ID: 29753831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophilic Esophagitis: Existing and Upcoming Therapies in an Age of Emerging Molecular and Personalized Medicine.
    Slack IF; Schwartz JT; Mukkada VA; Hottinger S; Abonia JP
    Curr Allergy Asthma Rep; 2020 Jun; 20(8):30. PubMed ID: 32506181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current options and investigational drugs for the treatment of eosinophilic esophagitis.
    Tamarit-Sebastian S; Ferrer-Soler FM; Lucendo AJ
    Expert Opin Investig Drugs; 2022 Feb; 31(2):193-210. PubMed ID: 35072575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state of biologics in treating eosinophilic esophagitis.
    Nhu QM; Aceves SS
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):15-20. PubMed ID: 36243282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.
    de Rooij WE; Dellon ES; Parker CE; Feagan BG; Jairath V; Ma C; Bredenoord AJ
    Drugs; 2019 Sep; 79(13):1419-1434. PubMed ID: 31352605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging therapies for eosinophilic esophagitis.
    Greuter T; Hirano I; Dellon ES
    J Allergy Clin Immunol; 2020 Jan; 145(1):38-45. PubMed ID: 31705907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
    Munoz-Persy M; Lucendo AJ
    Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic esophagitis: latest insights from diagnosis to therapy.
    Schoepfer A; Blanchard C; Dawson H; Lucendo A; Mauro A; Ribi C; Safroneeva E; Savarino EV; Penagini R
    Ann N Y Acad Sci; 2018 Dec; 1434(1):84-93. PubMed ID: 29762879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis.
    Otani IM; Nadeau KC
    Immunol Allergy Clin North Am; 2017 May; 37(2):369-396. PubMed ID: 28366483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics in eosinophilic esophagitis.
    Zhang S; Assa'ad AH
    Curr Opin Allergy Clin Immunol; 2021 Jun; 21(3):292-296. PubMed ID: 33769314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs.
    Ridolo E; Barone A; Ottoni M; Peveri S; Montagni M; Nicoletta F
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophilic esophagitis: review of nonsurgical treatment modalities.
    Reddy V; Ghaffari G
    Allergy Asthma Proc; 2013; 34(5):421-6. PubMed ID: 23998238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study.
    Lucendo AJ; Arias A; De Rezende LC; Yagüe-Compadre JL; Mota-Huertas T; González-Castillo S; Cuesta RA; Tenias JM; Bellón T
    J Allergy Clin Immunol; 2011 Nov; 128(5):1037-46. PubMed ID: 21880354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.